Cargando…

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19

Detalles Bibliográficos
Autor principal:	Polymeropoulos, Vasilios M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203551/ https://www.ncbi.nlm.nih.gov/pubmed/32426364 http://dx.doi.org/10.3389/fmed.2020.00192

Ejemplares similares

Does hydroxychloroquine combat COVID-19? A timeline of evidence
por: Alia, Erisa, et al.
Publicado: (2020)

Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility
por: Smieszek, Sandra P., et al.
Publicado: (2021)

Elevated plasma levels of CXCL16 in severe COVID-19 patients
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’
por: Smieszek, Sandra P., et al.
Publicado: (2021)

A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19
por: Hussain, Nowair, et al.
Publicado: (2020)

Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19()
por: Monte-Serrano, Juan, et al.
Publicado: (2020)

Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
por: Brufsky, Adam
Publicado: (2020)

Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662]
por: Smieszek, Sandra P., et al.
Publicado: (2022)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Controversial COVID-19 Cures: Hydroxychloroquine and Oleander Pediatric Ingestion Simulation Cases
por: Solano, Joshua J, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools
por: Hathout, Rania M., et al.
Publicado: (2020)

AI in Combating the COVID-19 Pandemic
Publicado: (2022)

Novel imaging techniques for hydroxychloroquine retinopathy
por: Yusuf, Imran H., et al.
Publicado: (2022)

A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
por: Mukherjee, Aveek, et al.
Publicado: (2020)

Hydroxychloroquine prescribing habits and impact of the COVID-19 pandemic
por: Kuraitis, Drew, et al.
Publicado: (2021)

An Agentic Familiarity: The Context of HIV/AIDS and Sexual Orientation for Older Canadians during the COVID-19 Pandemic
por: de Vries, Brian, et al.
Publicado: (2023)

Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review
por: Agarwal, Mudit, et al.
Publicado: (2020)

Unmet needs and future perspectives in hydroxychloroquine retinopathy
por: Yusuf, Imran H., et al.
Publicado: (2023)

Emergency Department Changes to Combat COVID-19 in Oman
por: Khilji, Muhammad Faisal, et al.
Publicado: (2021)

Emerging Technologies to Combat the COVID-19 Pandemic
por: Vaishya, Raju, et al.
Publicado: (2020)

Role of genomics in combating COVID-19 pandemic
por: Saravanan, K.A., et al.
Publicado: (2022)

Resilience to Combat the COVID-19 pandemic and beyond
por: Lee, Heeyoung
Publicado: (2021)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Hydroxychloroquine-based treatments in the CoViD-19 pandemic
Publicado: (2020)

Serious cardiac AEs with hydroxychloroquine during COVID-19 pandemic
Publicado: (2020)

Hydroxychloroquine: balancing the needs of LMICs during the COVID-19 pandemic
por: Banerjee, Soumya
Publicado: (2020)

Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic
por: Gagnon, Luke R., et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
por: Acharya, Yogesh, et al.
Publicado: (2020)

Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic
por: Coombes, Ian, et al.
Publicado: (2020)

Causes and trends of late diagnosis in Korean patients with hydroxychloroquine retinopathy
por: Ahn, Seong Joon, et al.
Publicado: (2023)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Use of telemedicine to combat the COVID-19 pandemic in Brazil
por: Carvalho, Carlos Roberto Ribeiro, et al.
Publicado: (2020)

Combating physical inactivity during the COVID-19 pandemic
por: Pinto, Ana Jéssica, et al.
Publicado: (2020)

Application of Tolerance Graphs to Combat COVID-19 Pandemic
por: Crnković, Dean, et al.
Publicado: (2021)

Application of omics technology to combat the COVID‐19 pandemic
por: Yang, Jingjing, et al.
Publicado: (2021)

Combating the COVID-19 pandemic: The role of disaster experience
por: Li, Jie, et al.
Publicado: (2022)

Applications of Healthcare Robots in Combating the COVID-19 Pandemic
por: Raje, Shruti, et al.
Publicado: (2021)

Economical synthesis of oxygen to combat the COVID-19 pandemic
por: Bhat, Nidhi, et al.
Publicado: (2023)

A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2
por: Musca, Serban C.
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmk3j2cr348jniuho5t52pqfjv